Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 4276-4279, December 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernandez-Pol, J. A.
Right arrow Articles by Johnson, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandez-Pol, J. A.
Right arrow Articles by Johnson, G. S.

Selective Toxicity Induced by Picolinic Acid in Simian Virus 40-transformed Cells in Tissue Culture1

J. A. Fernandez-Pol2 and George S. Johnson

Nuclear Medicine Laboratory, VA Hospital and St. Louis University, St. Louis, Missouri 63125 [J. A. F-P.], and Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland 20014 [G. S. J.]

When cultured normal and SV40-transformed normal rat kidney and BALB/3T3 cells were exposed to picolinic acid, cell proliferation ceases. Most of the normal cells remained in a quiescent G1(G0) state and viable for prolonged periods of time. In contrast, SV40-transformed cells progressed to the S and G2 phases of the cell cycle and remained viable only up to 90 to 120 hr. Then, most of the cells began to die. However, a very small fraction of the cell population (approximately 0.01%) developed into variants resistant to picolinic acid. Prevention of development of variants, and therefore destruction of all transformed cells, was obtained by addition of glycerol to picolinic acid-treated cells. Untransformed cells were unaffected by the same treatment. These results suggest that differential tumor toxicity should be feasible.

1 A portion of this study was supported by the Veterans Administration, MRISS 657/2620-01.

2 Supported during part of this work by an Individual National Research Service Award 1F32 CA05166-01 from the National Cancer Institute. To whom requests for reprints should be addressed, at Nuclear Medicine Laboratory (115JC), Veterans Administration Hospital, Saint Louis University, St. Louis, Mo. 63125.

Received 4/22/77. Accepted 8/25/77.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
G. J. Guillemin, K. M. Cullen, C. K. Lim, G. A. Smythe, B. Garner, V. Kapoor, O. Takikawa, and B. J. Brew
Characterization of the Kynurenine Pathway in Human Neurons
J. Neurosci., November 21, 2007; 27(47): 12884 - 12892.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.